尿液中的microrna不是多发性骨髓瘤的生物标志物。

Lenka Sedlaříková, Lenka Bešše, Soňa Novosadová, Veronika Kubaczková, Lenka Radová, Michal Staník, Marta Krejčí, Roman Hájek, Sabina Ševčíková
{"title":"尿液中的microrna不是多发性骨髓瘤的生物标志物。","authors":"Lenka Sedlaříková,&nbsp;Lenka Bešše,&nbsp;Soňa Novosadová,&nbsp;Veronika Kubaczková,&nbsp;Lenka Radová,&nbsp;Michal Staník,&nbsp;Marta Krejčí,&nbsp;Roman Hájek,&nbsp;Sabina Ševčíková","doi":"10.1186/s12952-015-0035-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In this study, we aimed to identify microRNA from urine of multiple myeloma patients that could serve as a biomarker for the disease.</p><p><strong>Results: </strong>Analysis of urine samples was performed using Serum/Plasma Focus PCR MicroRNA Panel (Exiqon) and verified using individual TaqMan miRNA assays for qPCR. We found 20 deregulated microRNA (p < 0.05); for further validation, we chose 8 of them. Nevertheless, only differences in expression levels of miR-22-3p remained close to statistical significance.</p><p><strong>Conclusions: </strong>Our preliminary results did not confirm urine microRNA as a potential biomarker for multiple myeloma.</p>","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12952-015-0035-7","citationCount":"7","resultStr":"{\"title\":\"MicroRNAs in urine are not biomarkers of multiple myeloma.\",\"authors\":\"Lenka Sedlaříková,&nbsp;Lenka Bešše,&nbsp;Soňa Novosadová,&nbsp;Veronika Kubaczková,&nbsp;Lenka Radová,&nbsp;Michal Staník,&nbsp;Marta Krejčí,&nbsp;Roman Hájek,&nbsp;Sabina Ševčíková\",\"doi\":\"10.1186/s12952-015-0035-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>In this study, we aimed to identify microRNA from urine of multiple myeloma patients that could serve as a biomarker for the disease.</p><p><strong>Results: </strong>Analysis of urine samples was performed using Serum/Plasma Focus PCR MicroRNA Panel (Exiqon) and verified using individual TaqMan miRNA assays for qPCR. We found 20 deregulated microRNA (p < 0.05); for further validation, we chose 8 of them. Nevertheless, only differences in expression levels of miR-22-3p remained close to statistical significance.</p><p><strong>Conclusions: </strong>Our preliminary results did not confirm urine microRNA as a potential biomarker for multiple myeloma.</p>\",\"PeriodicalId\":73849,\"journal\":{\"name\":\"Journal of negative results in biomedicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/s12952-015-0035-7\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of negative results in biomedicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s12952-015-0035-7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of negative results in biomedicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12952-015-0035-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

摘要

背景:在本研究中,我们旨在从多发性骨髓瘤患者的尿液中鉴定可作为该疾病生物标志物的microRNA。结果:使用血清/血浆焦点PCR MicroRNA Panel (Exiqon)对尿液样本进行分析,并使用qPCR的单个TaqMan miRNA检测进行验证。结论:我们的初步结果并没有证实尿液中的microRNA是多发性骨髓瘤的潜在生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

MicroRNAs in urine are not biomarkers of multiple myeloma.

MicroRNAs in urine are not biomarkers of multiple myeloma.

MicroRNAs in urine are not biomarkers of multiple myeloma.

Background: In this study, we aimed to identify microRNA from urine of multiple myeloma patients that could serve as a biomarker for the disease.

Results: Analysis of urine samples was performed using Serum/Plasma Focus PCR MicroRNA Panel (Exiqon) and verified using individual TaqMan miRNA assays for qPCR. We found 20 deregulated microRNA (p < 0.05); for further validation, we chose 8 of them. Nevertheless, only differences in expression levels of miR-22-3p remained close to statistical significance.

Conclusions: Our preliminary results did not confirm urine microRNA as a potential biomarker for multiple myeloma.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信